In contrast, in carcinomas, it is upregulated in CSCs to promote the transformation of M1 macrophages into the M2 phenotype and normal fibroblasts into cancer-associated fibroblasts (CAFs) by increasing TGF-β production, potentially driving malignancy via FPR activation. Here, TGFB1 is linked to carcinoma.